Fingolimod and Its Effects on Remyelination in Multiple Sclerosis
Author Information
Author(s): Jackson Samuel J, Giovannoni Gavin, Baker David
Primary Institution: Queen Mary University of London
Hypothesis
Fingolimod modulates microglial activation to enhance remyelination markers following demyelination.
Conclusion
Fingolimod enhances remyelination by modulating microglial activation and reducing inflammatory markers.
Supporting Evidence
- Fingolimod significantly increased myelin basic protein levels after demyelination.
- Fingolimod reduced levels of inflammatory markers like TNF-alpha and IL-1b.
- Fingolimod decreased apoptosis markers in treated cultures.
Takeaway
Fingolimod helps the brain repair itself after damage by calming down certain immune cells.
Methodology
The study used a rat cell culture model to examine the effects of fingolimod on remyelination after demyelination induced by lysophosphatidyl choline.
Limitations
The study was conducted in vitro, which may not fully replicate in vivo conditions.
Participant Demographics
Sprague Dawley rats were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website